Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery of a selective OX1 receptor antagonist for substance abuse and dependency

Sep. 5, 2019

First patient dosed in phase I study of RBN-2397

Sep. 5, 2019

Tiziana Life Sciences reports positive phase IIa data for milciclib in HCC

Sep. 5, 2019

CC-90011 demonstrates promising activity in models of SCLC

Sep. 5, 2019

Preclinical and phase I data presented for SAR-439859

Sep. 5, 2019

Discovery of novel R-PTP-sigma inhibitors to promote hematopoietic stem cell regeneration

Sep. 5, 2019

Soluble RANKL inhibition may prevent tumor metastasis to bone

Sep. 5, 2019

Antimalarial kinase inhibitor identified at the University of Glasgow

Sep. 5, 2019

CRISPR targets fat cells, improves metabolism

Sep. 5, 2019

Evaluation of the effects of atractylenolide I in a new mouse model of cancer cachexia

Sep. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...